By (@EricTopol)
The 1st @US_FDA approved deep learning #AI device for 1°care today: diagnosis of diabetic retinopathy w/o ophthalmologists. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604357 …
But no published data. Website claims 87% sensitivity, 90% specificity from 900 patient trial.
+ @SGottliebFDA‘s upbeat #AI tweets. pic.twitter.com/ScphZajXVg
Source:: https://twitter.com/EricTopol/status/984244031122169856
